Compare HCAC & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCAC | LRMR |
|---|---|---|
| Founded | 2025 | N/A |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 292.3M | 280.0M |
| IPO Year | N/A | 2014 |
| Metric | HCAC | LRMR |
|---|---|---|
| Price | $10.00 | $5.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $16.14 |
| AVG Volume (30 Days) | 49.3K | ★ 5.6M |
| Earning Date | 01-01-0001 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.00 | $1.61 |
| 52 Week High | $10.06 | $6.42 |
| Indicator | HCAC | LRMR |
|---|---|---|
| Relative Strength Index (RSI) | 24.70 | 74.86 |
| Support Level | N/A | $3.22 |
| Resistance Level | $10.03 | N/A |
| Average True Range (ATR) | 0.01 | 0.43 |
| MACD | -0.00 | 0.27 |
| Stochastic Oscillator | 0.00 | 79.35 |
Hall Chadwick Acquisition Corp is a blank check company.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.